|
|
| Line 35: |
Line 35: |
| |} | | |} |
|
| |
|
| ==WHO Essential and Desirable Genetic Diagnostic Criteria==
| |
| {| class="wikitable"
| |
| |+
| |
| |WHO Essential Criteria (Genetics)*
| |
| |Detection of ''BCR::ABL1'' at initial diagnosis.
| |
| |-
| |
| |WHO Desirable Criteria (Genetics)*
| |
| |Presence of t(9;22)(q34;q11.2) on conventional karyotyping; determination of the ''BCR::ABL1'' transcript subtype and establishment of a baseline level of ''BCR::ABL1'' transcript subtype and establishment of a baseline level of ''BCR::ABL1'' transcript for monitoring treatment response.
| |
| |-
| |
| |Other Classification
| |
| |N/A
| |
| |}
| |
| <nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>].
| |
| ==Related Terminology== | | ==Related Terminology== |
|
| |
|
